SCHEDULE 13G 0001738048 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 04/08/2025 0001796280 ORIC Pharmaceuticals, Inc. 68622P109 240 E. Grand Ave, 2nd Floor South San Francisco CA 94080 Rule 13d-1(c) Venrock Healthcare Capital Partners III, L.P. a DE 0.00 6596885.00 0.00 6596885.00 6596885.00 7.7 PN VHCP Co-Investment Holdings III, LLC a DE 0.00 6596885.00 0.00 6596885.00 6596885.00 7.7 OO Venrock Healthcare Capital Partners EG, L.P. a DE 0.00 6596885.00 0.00 6596885.00 6596885.00 7.7 PN VHCP Management III, LLC a DE 0.00 6596885.00 0.00 6596885.00 6596885.00 7.7 OO VHCP Management EG, LLC a DE 0.00 6596885.00 0.00 6596885.00 6596885.00 7.7 OO Nimish Shah a X1 0.00 6596885.00 0.00 6596885.00 6596885.00 7.7 IN Bong Y Koh a X1 0.00 6596885.00 0.00 6596885.00 6596885.00 7.7 IN ORIC Pharmaceuticals, Inc. 240 E. Grand Ave, 2nd Floor, South San Francisco, CA, 94080. The names of the persons filing this report (collectively, the "Reporting Persons") are: Venrock Healthcare Capital Partners III, L.P. ("VHCP III") VHCP Co-Investment Holdings III, LLC ("VHCP Co-Investment III") Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG") VHCP Management III, LLC ("VHCP Management III") VHCP Management EG, LLC ("VHCP Management EG") Nimish Shah ("Shah") Bong Koh ("Koh") The Reporting Persons are members of a group for the purposes of this Schedule 13G. New York Office: 7 Bryant Park, 23rd Floor New York, NY 10018 Palo Alto Office: 3340 Hillview Avenue Palo Alto, CA 94304 All of the entities were organized in Delaware. Shah and Koh are both United States citizens. Y Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of shares of the Issuer beneficially owned by such Reporting Person as of May 29, 2025 and is incorporated by reference. The Reporting Persons' ownership of the Issuer's securities consists of (i) 1,240,206 shares of Common Stock held by VHCP III, (ii) 124,041 shares of Common Stock held by VHCP Co-Investment III, and (iii) 5,232,638 shares of Common Stock held by VHCP EG. VHCP Management III is the general partner of VHCP III and the manager of VHCP Co-Investment III. VHCP Management EG is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCP Management III and VHCP Management EG. Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the shares of the Issuer beneficially owned by such Reporting Person as of May 29, 2025 and is incorporated by reference. The percentage set forth in each row 11 is based upon an estimated 85,218,393 shares of common stock outstanding as of May 29, 2025, which is the sum of (i) 71,088,080 shares of common stock outstanding as of April 28, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on May 5, 2025, and (ii) 14,130,313 shares of common stock issued upon the closing of a private placement on May 29, 2025. Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of May 29, 2025 and is incorporated by reference. Row 6 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of May 29, 2025 and is incorporated by reference. Row 7 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of May 29, 2025 and is incorporated by reference. Row 8 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of May 29, 2025 and is incorporated by reference. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 24.1 Power of Attorney for Nimish Shah Exhibit 24.2 Power of Attorney for Bong Koh Exhibit 99.1 Joint Filing Agreement Venrock Healthcare Capital Partners III, L.P. /s/ Sherman G. Souther 05/30/2025 VHCP Co-Investment Holdings III, LLC /s/ Sherman G. Souther 05/30/2025 Venrock Healthcare Capital Partners EG, L.P. /s/ Sherman G. Souther 05/30/2025 VHCP Management III, LLC /s/ Sherman G. Souther 05/30/2025 VHCP Management EG, LLC /s/ Sherman G. Souther 05/30/2025 Nimish Shah /s/ Sherman G. Souther 05/30/2025 Bong Y Koh /s/ Sherman G. Souther 05/30/2025